Ignite Creation Date:
2025-12-24 @ 3:03 PM
Ignite Modification Date:
2026-02-02 @ 1:57 AM
Study NCT ID:
NCT01243359
Status:
COMPLETED
Last Update Posted:
2014-04-02
First Post:
2010-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Clear Cell Renal Cell Carcinoma | View |
| None | Recurrent Renal Cell Cancer | View |
| None | Stage I Renal Cell Cancer | View |
| None | Stage II Renal Cell Cancer | View |
| None | Stage III Renal Cell Cancer | View |
| None | Stage IV Renal Cell Cancer | View |
| None | Unspecified Adult Solid Tumor, Protocol Specific | View |
Keywords: